SLC16A2 and Allan-Herndon-Dudley syndrome: Mutations in SLC16A2 are the cause of Allan-Herndon-Dudley syndrome, associated with impaired thyroid metabolism, presenting with neurodevelopmental delay, hypertonia, and muscle weakness [63].